Peptides for Growth Hormone
Comprehensive guide to 2 peptides researched for growth hormone, ranked by evidence strength from FDA-approved to early preclinical. Each compound is evaluated on mechanism, clinical status, and safety profile.
Overview
2 research peptides are currently studied for growth hormone. This guide ranks them by evidence strength and covers their mechanisms, safety profiles, and current clinical status.
Ghrelin — Well-characterized endogenous hormone with approved analogs
Evidence Rating: B
Category: Growth Hormone / Appetite
Ghrelin is a 28-amino acid peptide hormone produced primarily by the stomach that serves as the endogenous ligand for the growth hormone secretagogue receptor (GHS-R1a). It is the only known circulating orexigenic (appetite-stimulating) hormone. Ghrelin stimulates growth hormone release, increases a...
Key claims: Stimulates growth hormone release; Potent appetite stimulation.
CJC-1295 with DAC — Phase I-II data; research compound
Evidence Rating: C
Category: Growth Hormone
CJC-1295 with DAC (Drug Affinity Complex) is a modified growth hormone-releasing hormone (GHRH) analog with a unique lysine-linked maleimidopropionic acid moiety that covalently binds to circulating albumin in vivo. This albumin binding extends the half-life from minutes (native GHRH) to approximate...
Key claims: Sustained growth hormone elevation; Convenient weekly dosing schedule.
Shop Research Peptides
CJC-1295 DAC 5mg
5mg
Retatrutide 20mg
20mg
BPC-157 5mg
5mg
Ipamorelin 10mg
10mg
Semaglutide 10mg
10mg
TB-500 5mg
5mg
Retatrutide 10mg
10mg
GHK-Cu 50mg
50mg
Sermorelin 5mg
5mg
Quality Documentation
Review batch documentation before making research purchasing decisions. Volta pairs product education with COA literacy so researchers can evaluate purity, identity, lot details, and testing context.
Product cards on this page link to current catalog entries and available quality documentation.
Related Research News
CJC-1295 with DAC and Ipamorelin: Growth Hormone Research Guide
CJC-1295 with DAC and Ipamorelin represent key compounds in growth hormone research, targeting distinct pathways for GH and IGF-1 signaling. CJC-1295 with DAC acts as a long-acting GHRH analogue with a half-life of 5.8 to 8.1 days, while Ipamorelin functions as a selective growth hormone secretagogue via the ghrelin receptor. Together, they support studies on metabolism, recovery, and body composition.
Ipamorelin vs GHRP-2: Which Offers More Targeted GH Release?
Ipamorelin and GHRP-2 both stimulate growth hormone release via the ghrelin receptor, but Ipamorelin provides more selective action with minimal impact on other hormones like ACTH and cortisol. GHRP-2 delivers stronger GH pulses alongside broader endocrine effects. Combining them can enhance overall GH output through additive receptor stimulation.
Peptide Tools
Follow Research Updates
Get new research pages, product updates, tool releases, and quality resources from Volta.
Subscribe